Page last updated: 2024-12-05

diethylene glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethylene glycol (DEG) is a colorless, odorless, viscous liquid with a sweet taste. It is a synthetic compound, produced through the reaction of ethylene oxide with ethylene glycol. DEG is a hygroscopic substance, meaning it readily absorbs moisture from the air. DEG is used in various industrial applications, including antifreeze, brake fluid, and as a solvent for paints, resins, and dyes. However, DEG is also toxic to humans and can cause severe health problems, including kidney failure and death. DEG contamination in food and beverages has been a recurring issue, leading to widespread illness and fatalities. The toxicity of DEG arises from its metabolism in the body, which generates toxic byproducts that damage organs, particularly the kidneys. Due to its potential health risks, regulations have been put in place to limit its use in consumer products. Research on DEG focuses on understanding its toxicity mechanisms, developing analytical methods for its detection, and exploring alternative chemicals with similar industrial properties but without the associated health risks.'

glycol ether : A hydroxyether which contains both an ether and alcohol functional groups. It is one of the most versatile classes of organic solvents which are commonly used in paints, cleaners, adhesives, pharmaceuticals and cosmetics. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8117
CHEMBL ID1235226
CHEBI ID46807
SCHEMBL ID1462
MeSH IDM0061284

Synonyms (175)

Synonym
BIDD:ER0301
CHEMBL1235226
nsc35746
ethylene diglycol
nsc-35745
glycol ether
wln: q2o2q
2,2-di(hydroxyethyl) ether
diglycol
nsc32856
nsc35745
nsc35744
3-oxa-1,5-pentanediol
digenos
ethanol,2'-oxybis-
deg ,
111-46-6
nsc-35744
3-oxapentane-1,5-diol
nsc32855
bis(.beta.-hydroxyethyl) ether
nsc-35746
dissolvant apv
2,2'-0xydiethanol
deactivator h
digol
tl4n
2,2'-oxydiethanol
diethylene glycol
2,2'-oxybis[ethanol]
peg 600
dicol
nsc-36391
deactivator e
.beta.,.beta.'-dihydroxydiethyl ether
brecolane ndg
ethanol,2'-oxydi-
nsc36391
2,2'-oxyethanol
bis(2-hydroxyethyl) ether
nsc-32855
peg 400
peg 200
nsc-32856
ethanol, 2,2'-oxybis-
di(hydroxyethyl)ether
2,2'-oxybisethanol
2-(2-hydroxyethoxy)ethanol
NCGC00090703-01
1,5-dihydroxy-3-oxapentane
ethanol, 2,2'-oxydi-
ccris 2193
diethylenglykol [czech]
nsc 36391
caswell no. 338a
ai3-08416
dihydroxydiethyl ether
hsdb 69
epa pesticide chemical code 338200
einecs 203-872-2
2,2'-dihydroxyethyl ether
3-oxapentamethylene-1,5-diol
brn 0969209
(2s,4r,6r,6as)-4-(2-amino-6-oxo-1,6-dihydropurin-9-yl)-6-(hydroxymethyl)-tetrahydrofuro[3,4-d][1,3]dioxol-2-ylphosphonic acid
inchi=1/c4h10o3/c5-1-3-7-4-2-6/h5-6h,1-4h
diethylene glycol, reagentplus(r), 99%
2-hydroxyethyl ether
beta,beta'-dihydroxydiethyl ether
CHEBI:46807 ,
2,2'-dihydroxydiethyl ether
bis(beta-hydroxyethyl) ether
diethylenglykol
MLS001055330
smr000112132
diethylene glycol, bioultra, >=99.0% (gc)
diethylene glycol, puriss. p.a., >=99.0% (gc), colorless
9BAE4479-A6DD-4206-83C1-AB625AB87665
diethyleneglycol
D0495
AKOS000120101
A802367
NCGC00090703-02
NCGC00090703-03
cas-111-46-6
dtxsid8020462 ,
tox21_201616
NCGC00259165-01
NCGC00253996-01
dtxcid20462
tox21_300064
HMS2270G18
diethylene glycol (deg)
1ka ,
STL280303
ec 203-872-2
61br964293 ,
4-01-00-02390 (beilstein handbook reference)
unii-61br964293
FT-0624892
2-(2-hydroxyethoxy) ethanol-d8
peg35000
BP-20527
BP-31030
BP-31029
peg4000
diethylene glycol [usp-rs]
diethylene glycol [mi]
diethylene glycol ether
diethylene glycol [inci]
2,2-oxydi(ethan-1-ol)
diethylene glycol [hsdb]
etofenamate impurity f [ep impurity]
glycerol impurity a [ep impurity]
SCHEMBL1462
2-(2-hydroxyethoxyl)ethan-1-ol
2-hydroxyethylether
2-(2-hydroxy-ethoxy)-ethanol
ho(ch2ch2o)2h
bis(2-hydroxyethyl)ether
diethyene glycol
diehyleneglycol
bis-(2-hydroxyethyl)ether
di-ethylene glycol
diethylene-glycol
ho(ch2)2o(ch2)2oh
2-(2-hydroxyethoxy)ethan-1-ol
.beta.,.beta.'-dihydroxyethyl ether
glycol hydroxyethyl ether
1,4,10,13-tetraoxa-7,16-diazacyclooctadecane, 7,16-bis(1-oxodecyl)-
mfcd00002882
BP-22990
peg6000
BP-23304
peg2000
J-002580
F1908-0125
diethylene glycol, united states pharmacopeia (usp) reference standard
diethylene glycol, analytical standard
diethylene glycol, saj first grade, >=98.0%
diethylene glycol, 99%
diethylene glycol, vetec(tm) reagent grade, 98%
diethylene glycol, lr, >=99%
2,2'-oxydiethanol; etofenamate imp. f (ep); etofenamate impurity f; glycerol impurity a
2,2'-oxybis(ethan-1-ol)
Q421902
149626-00-6
diethyl ene glycol
105400-04-2
chromate(2-), 2-5-(2,5-dichlorophenyl)azo-2-(hydroxy-.kappa.o)phenylmethyleneamino-.kappa.nbenzoato(
FS-3891
CS-0014055
oh-peg2-oh
BP-25804
BP-25805
peg 10,000
peg 20,000
2,2'-oxydiethanol, 2-hydroxyethyl ether
E83357
31290-76-3
EN300-19318
diethylenglykol rein
glycerol impurity a (ep impurity)
diethylene glycol (usp-rs)
glicole dietilenico
3-oxa-1, 5-pentanediol
2-hydroxyethoxyethanol
2,2'-ossidietanolo
2,2'-oxibesethanol
2,2-oxybisethanol
2,2'-oxybis(ethanol)
3-oxypentane-1,5-diol
diglykol
diethyleneglykol
BP-31245
peg600

Research Excerpts

Overview

Diethylene glycol (DEG) is a common industrial solvent which is responsible for accidental and epidemic poisoning as early as the 1930s. It has minor uses as a solvent or antifreeze in consumer products; these minor uses could result in potential human exposure. Diethylene Glycol serves as a cheap and environmentally friendly equiva.

ExcerptReferenceRelevance
"Diethylene glycol (DEG) is an organic compound that has been found as an adulterant in consumer products as a counterfeit glycerin. "( Histopathological evidence that diethylene glycol produces kidney and nervous system damage in rats.
Cuevas-Ocampo Areli, K; Dayton Robert, D; Fitzgerald Joseph, S; Flowers Ashley, B; Jamison Courtney, N; McKinney Mary, P; McMartin Kenneth, E; Mitchell Hannah, G; Nam Hyung, W; Steib Mattie, E; Toups Colton, R, 2022
)
2.45
"Diethylene glycol (DEG) is an industrial solvent with many uses, including brake fluids. "( Symptomatic Diethylene Glycol Ingestion Successfully Treated with Fomepizole Monotherapy.
Clark, RF; Corbett, B; Lasoff, DR; Seltzer, JA, 2022
)
2.54
"Diethylene glycol (DEG) is an organic compound found in household products but also as a counterfeit solvent in medicines. "( Diethylene glycol produces nephrotoxic and neurotoxic effects in female rats.
Dayton, RD; Jamison, CN; Latimer, B; McKinney, MP; McMartin, KE; Mitchell, HG, 2022
)
3.61
"Diethylene glycol (DEG) is an organic chemical that is used mostly as a chemical intermediate and has minor uses as a solvent or antifreeze in consumer products; these minor uses could result in potential human exposure. "( Human health assessment for long-term oral ingestion of diethylene glycol.
Banton, MI; Klapacz, J; McMartin, KE; Reitman, F; Snellings, WM, 2017
)
2.14
"Diethylene glycol is a toxic industrial solvent responsible for more than 13 mass poisonings since 1937. "( Clinical, laboratory, diagnostic, and histopathologic features of diethylene glycol poisoning--Panama, 2006.
Rodriguez, GM; Schier, JG; Sejvar, JJ; Sosa, NR, 2014
)
2.08
"Diethylene glycol is a common industrial solvent which is responsible for accidental and epidemic poisoning as early as the 1930s. "( Neurological manifestation of recreational fatal and near-fatal diethylene glycol poisonings: case series and review of literature.
Deleu, D; Elalamy, O; Imam, YZB; Kamran, S; Karim, H; Osman, Y; Sokrab, T, 2014
)
2.08
"Diethylene glycol (DEG) is a chemical compound used during offshore oil activities to prevent hydrate formation, and it may be released into the sea. "( Ecotoxicity of diethylene glycol and risk assessment for marine environment.
Canepa, S; Cicero, AM; Manfra, L; Mannozzi, M; Rotini, A; Savorelli, F; Tornambè, A, 2015
)
2.21
"Diethylene glycol serves as a cheap and environmentally friendly equivalent of ethyne, with the release of H2O and alcohol as clean wastes."( Diethylene Glycol Serving as Ethyne Equivalent: A Sustainable Approach toward 2,3-Disubstituted Furan.
Cheng, J; Chu, H; Jiang, Y; Peng, H; Shi, B; Sun, S; Yu, JT, 2015
)
2.58
"Diethylene glycol (DEG) is a clear, colorless, practically odorless, viscous, hygroscopic liquid with a sweetish taste. "( Diethylene glycol poisoning.
Beasley, DM; Schep, LJ; Slaughter, RJ; Temple, WA, 2009
)
3.24
"Diethylene glycol (DEG) is an industrial chemical, the misuse of which has led to numerous epidemic poisonings worldwide. "( Inhibition of metabolism of diethylene glycol prevents target organ toxicity in rats.
Adegboyega, PA; Bartels, M; Besenhofer, LM; Filary, MJ; McLaren, MC; McMartin, KE; Perala, AW, 2010
)
2.1
"Diethylene glycol is a toxic alcohol used as an industrial solvent in various products. "( Management of diethylene glycol ingestion.
Hoyte, CO; Leikin, JB, 2012
)
2.18
"Diethylene glycol (DEG) is a well-known metabolic and renal toxin usually ingested accidentally as an ethanol substitute or as a contaminant in various medicinals. "( Delayed neurologic sequelae resulting from epidemic diethylene glycol poisoning.
Alfred, S; Coleman, P; Graudins, A; Harris, D; Stachowski, E; Wigmore, T, 2005
)
2.02
"Diethylene glycol (DEG) is a widely used substance with various risks of intoxication. "( Nephrotoxic effects of diethylene glycol (DEG) in rats.
Bräunlich, H; Jahn, F; Kraul, H, 1991
)
2.03

Effects

DEG has caused many cases of acute kidney injury and deaths worldwide. Diethylene glycol ingestion has been associated with the development of optic nerve injury, cranial nerve deficits, quadraparesis and peripheral neuropathy.

ExcerptReferenceRelevance
"Diethylene glycol (DEG) has caused many cases of acute kidney injury and deaths worldwide. "( Diglycolic acid, the toxic metabolite of diethylene glycol, chelates calcium and produces renal mitochondrial dysfunction in vitro.
Aw, TY; Conrad, T; Landry, GM; McMartin, KE; Nichols, R, 2016
)
2.14
"Diethylene glycol ingestion has been associated with the development of optic nerve injury, cranial nerve deficits, quadraparesis and peripheral neuropathy."( Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisonings.
Lewis, LD; Reddy, NJ; Sudini, M, 2010
)
1.33

Toxicity

ExcerptReferenceRelevance
" The toxic effects of DEG in rats with pre-existing liver cirrhosis are significantly reduced, which may be due to the decreased hepatic ADH activity."( Pre-existing liver cirrhosis reduced the toxic effect of diethylene glycol in a rat model due to the impaired hepatic alcohol dehydrogenase.
, 2011
)
0.61
" Although these studies suggest that either metabolite may be involved in producing kidney toxicity, the unexpected renal accumulation of DGA at toxic doses of DEG suggests that it must also be considered a possible toxic metabolite of DEG."( Role of tissue metabolite accumulation in the renal toxicity of diethylene glycol.
Bartels, M; Besenhofer, LM; Filary, MJ; Latimer, B; McLaren, MC; McMartin, KE; Perala, AW, 2011
)
0.61
"5 g/l) for PWs discharged at sea is safe for marine environment."( Toxicity evaluation of diethylene glycol and its combined effects with produced waters of off-shore gas platforms in the Adriatic Sea (Italy): bioassays with marine/estuarine species.
Cicero, AM; Faraponova, O; Magaletti, E; Manfra, L; Mariani, L; Onorati, F; Savorelli, F; Tornambè, A; Virno Lamberti, C, 2012
)
0.69
" We have evaluated long-term toxic effects of DEG on indicator species of the marine environment as algae (Phaeodactylum tricornutum), crustaceans (Artemia franciscana), molluscs (Tapes philippinarum) and fish (Dicentrarchus labrax)."( Ecotoxicity of diethylene glycol and risk assessment for marine environment.
Canepa, S; Cicero, AM; Manfra, L; Mannozzi, M; Rotini, A; Savorelli, F; Tornambè, A, 2015
)
0.77
" This study identified NaDC-1 as a likely and NaDC-3 as a possible molecular target to reduce uptake of this toxic metabolite by the kidney."( Role of Plasma Membrane Dicarboxylate Transporters in the Uptake and Toxicity of Diglycolic Acid, a Metabolite of Diethylene Glycol, in Human Proximal Tubule Cells.
Dwyer, D; Landry, GM; Luttrell-Williams, ES; McMartin, KE; Robinson, CN; Tobin, JD, 2022
)
0.93

Bioavailability

ExcerptReferenceRelevance
" Oral doses were well absorbed and excreted primarily (approximately 80%) in urine within 24 hr of administration."( Metabolism and disposition of diethylene glycol in rat and dog.
Mathews, JM; Matthews, HB; Parker, MK,
)
0.42
"The design, synthesis and characterization of a series of zero generation (G0) PAMAM dendrimer-based prodrugs for the potential enhancement of drug solubility and bioavailability are described."( Synthesis, characterization and stability of dendrimer prodrugs.
Attwood, D; D'Emanuele, A; Freeman, S; Najlah, M, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" The hamsters were dosed by (single) intraperitoneal injection because previous experiments had indicated that oral dosing in the drinking water (and therefore possibly gavage dosing also) causes the hamsters to drink less."( Fetal detriment used as an index of effects of diethylene glycol on Syrian hamster fetuses.
Cameron, KM; Renwick, JH, 1992
)
0.54
" The mean total dosage per mouse was 2110."( [Carcinogenic activity of ethylene oxide and its reaction products 2-chloroethanol, 2-bromoethanol, ethylene glycol and diethylene glycol. III. Research on ethylene glycol and diethylene glycol for carcinogenic effects].
Dunkelberg, H, 1987
)
0.48
" Timed-pregnant CD-1 mice and CD rats were dosed daily by gavage with undiluted DEG over gestational days (gd) 6-15."( Developmental toxicity study with diethylene glycol dosed by gavage to CD rats and CD-1 mice.
Ballantyne, B; Snellings, WM, 2005
)
0.61
" Sea bass (Dicentrarchus labrax) were exposed to DEG dosed alone or in combination with PWs from an Adriatic platform."( Biological effects of diethylene glycol (DEG) and produced waters (PWs) released from offshore activities: a multi-biomarker approach with the sea bass Dicentrarchus labrax.
Barbara, P; Claudia, VL; Francesco, R; Ginevra, M; Maura, B; Stefania, G, 2009
)
0.67
"The limited data available suggest that fomepizole, using the same dosage regimen as that used for adults, is efficacious and well tolerated in pediatric patients."( Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings.
Brent, J, 2010
)
0.61
" The obtained polyelectrolyte hydrogels by their homogeneity, dehydration and rheological characteristics may be of concern in function of matrices to create external prolonged-action dosage forms."( [The study of quality characteristics of the hydrogel ointments and films based on copolymers divinyl esters of diethylene glycol].
Akhmetova, SB; Bakirova, RE; Fazylov, SD; Muravleva, LE; Tazhbaeva, EM, 2014
)
0.61
"Repeated dosing with DEG in a female model produced nephrotoxic effects at a dose similar to that in males."( Diethylene glycol produces nephrotoxic and neurotoxic effects in female rats.
Dayton, RD; Jamison, CN; Latimer, B; McKinney, MP; McMartin, KE; Mitchell, HG, 2022
)
2.16
" This dosing paradigm resulted in approximately 25 % of the DEG-treated animals developing AKI and also neurotoxicity (sensorimotor dysfunction and elevated cerebrospinal fluid (CSF) protein)."( Histopathological evidence that diethylene glycol produces kidney and nervous system damage in rats.
Cuevas-Ocampo Areli, K; Dayton Robert, D; Fitzgerald Joseph, S; Flowers Ashley, B; Jamison Courtney, N; McKinney Mary, P; McMartin Kenneth, E; Mitchell Hannah, G; Nam Hyung, W; Steib Mattie, E; Toups Colton, R, 2022
)
1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxyetherAny ether carrying a hydroxy group at unspecified position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency4.45570.000714.592883.7951AID1259369
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency31.54360.013326.981070.7614AID1346978
thyroid stimulating hormone receptorHomo sapiens (human)Potency10.00000.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency66.43790.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.88950.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency36.91580.001530.607315,848.9004AID1224841; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency25.11890.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency62.93780.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency55.75640.000229.305416,493.5996AID743069
caspase-3Homo sapiens (human)Potency31.54360.013326.981070.7614AID1346978
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency50.419619.739145.978464.9432AID1159509
mitogen-activated protein kinase 1Homo sapiens (human)Potency3.16230.039816.784239.8107AID995
gemininHomo sapiens (human)Potency0.06510.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (270)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (14.81)18.7374
1990's30 (11.11)18.2507
2000's66 (24.44)29.6817
2010's104 (38.52)24.3611
2020's30 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 65.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index65.21 (24.57)
Research Supply Index5.70 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index111.77 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (65.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.34%)5.53%
Reviews13 (4.38%)6.00%
Case Studies23 (7.74%)4.05%
Observational0 (0.00%)0.25%
Other260 (87.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]